Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea.

Choe, Sunho; Talanova, Oxana; Shin, Sooyoun; Syrkina, Olga; Fournier, Marion

Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea.

Choe, Sunho; Talanova, Oxana; Shin, Sooyoun; Syrkina, Olga; Fournier, Marion.

Afiliación

Choe S; Sanofi, 235 Banpo-daero, Seocho-Gu, Seoul, 06578, South Korea. sunho.choe@sanofi.com.
Talanova O; Sanofi, Lyon, France.
Shin S; Sanofi, 235 Banpo-daero, Seocho-Gu, Seoul, 06578, South Korea.
Syrkina O; Sanofi, Swiftwater, PA, USA.
Fournier M; Sanofi, Lyon, France.

Infect Dis Ther ; 12(6): 1715-1723, 2023 Jun.

Article en En | MEDLINE | ID: mdl-37300743

Palabras clave

Children; Influenza; Post-marketing surveillance study; Quadrivalent inactivated split-virion influenza vaccine; Safety; South Korea; VaxigripTetra

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Screening_studies Idioma: En Revista: Infect Dis Ther Año: 2023 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google